Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-r5zm4 Total loading time: 0 Render date: 2024-06-15T13:45:11.326Z Has data issue: false hasContentIssue false

Chapter 1 - Introduction

Published online by Cambridge University Press:  16 February 2022

David Mortimer
Affiliation:
Oozoa Biomedical Inc., Vancouver
Lars Björndahl
Affiliation:
Karolinska Institutet, Stockholm
Christopher L. R. Barratt
Affiliation:
University of Dundee
José Antonio Castilla
Affiliation:
HU Virgen de las Nieves, Granada
Roelof Menkveld
Affiliation:
Stellenbosch University, South Africa
Ulrik Kvist
Affiliation:
Karolinska Institutet, Stockholm
Juan G. Alvarez
Affiliation:
Centro ANDROGEN, La Coruña
Trine B. Haugen
Affiliation:
Oslo Metropolitan University

Summary

Gives an overview of the role of semen analysis and spern function testing in the assessment of the reproductive system in adrology and in the aetiology of male factor infertility. Considers the convergence of semen anaysis reference methodology and the vital importance of training in achieving competency and controlling measurement uncertainty. Discusses how the andrology laboratory provides test results that help direct patient management, and the importance of safe and effective sperm preparation as part of assisted conception treatments.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2022

Male subfertility is a very significant global problem. Epidemiological data show that approximately one in seven couples are classified as subfertile [Reference Hull, Glazener and Kelly1]. Sperm dysfunction is the single most common cause of male subfertility. An older study employing a sperm concentration cut-off of <20 × 106/ml found that 20% of 18-year-old men were classed as subfertile [Reference Andersen, Jensen and Carlsen2]. Although it is too simplistic to base a classification of subfertility solely on sperm concentration, the reported frequency of male subfertility points to a high proportion of the population being affected, compared with other prevalent diseases such as diabetes. What is more worrying is the likelihood that sperm counts are falling and the prevalence of male subfertility is increasing [Reference Sharpe and Irvine3,Reference Levine, Jørgensen and Martino-Andrade4]. Moreover, male fertility has been shown to be a barometer of overall health and longevity [Reference Glazer, Bonde and Eisenberg5Reference Kasman, Del Giudice and Eisenberg7], and significant evidence suggests that the health of future generations may be influenced epigenetically by the quality of their father’s spermatozoa, which may have been altered by his diet and/or lifestyle [Reference Lane, Robker and Robertson8Reference Wright, Aitken, Mortimer and Kovacs10]; perhaps such effects underlie the fall in sperm counts [Reference Levine, Jørgensen and Martino-Andrade4]. In addition, there are many substances and products that are toxic to spermatozoa in our everyday environment [Reference Mortimer, Barratt and Björndahl11]. Unfortunately, little progress has been made towards answering fundamental questions in andrology or in developing new diagnostic tools or alternative management strategies for infertile men other than ICSI [Reference Barratt, De Jonge and Sharpe12,Reference Aitken13]. A recent expert meeting highlighted evidence gaps and important research areas, and proposed a strategic approach whereby andrology might make the rapid progress necessary to address key scientific, clinical, and societal challenges that face our discipline [14]. Andrology is therefore a pivotal discipline in modern medicine, and it is against this background that we have updated this handbook.

Semen analysis provides a comprehensive view of the reproductive functioning of the male partner of the subfertile couple. It includes assessments of sperm count (which reflects sperm production, transport through the male genital tract and ejaculatory function), sperm motility (a basic functional marker of likely sperm competence), sperm vitality (to distinguish between dead spermatozoa and live, immotile spermatozoa), sperm form (aspects of sperm production and maturation), and the physical appearance of the ejaculate (semen production). In addition to this basic semen assessment there are further tests that can be performed – what we have termed extended semen analysis – permitting further analyses that assess more functional aspects of the semen sample. Such tests include biochemical examinations to evaluate the secretions from the auxiliary sex glands, the detection of anti-sperm antibodies, and the use of computer-aided sperm analysis (CASA) to examine sperm motility patterns (‘kinematics’, see Chapter 6).

A high quality, comprehensive semen assessment is not just the cornerstone of the diagnosis of male subfertility, it is also the starting point for providing prognostic information. While the basic semen assessment has been performed for over 70 years, there have been a number of studies questioning the value of the traditional semen characteristics (sperm concentration, motility and morphology) in the diagnosis and prognosis of male subfertility [Reference Björndahl and Barratt15]. Partly, this is the result of an incomplete understanding of what clinical information a semen assessment can provide (see below), but primarily it is because the basic assessments are usually performed using inadequate methods with limited understanding of the technical requirements and poor quality assurance [Reference Björndahl, Barratt, Mortimer and Jouannet16]. An enduring example of this is the UK survey of laboratories performing ‘andrology tests’, which showed dramatic variation from WHO recommended procedures leading to uncritical reporting of results [Reference Riddell, Pacey and Whittington17,Reference Zuvela and Matson18].

In this handbook we provide a detailed, step-by-step guide using robust methods for examining human semen. We have also included a comprehensive explanation of staff training, and sections on Quality Control, Quality Assurance and Quality Improvement. Adoption of such methods and procedures will lead to a significant improvement in the quality of the data produced by an andrology laboratory, and therefore more robust clinical information. At the time of completing this book (August 2021), during the second year of the COVID-19 pandemic, we have at last seen the convergence of basic semen analysis methodology between the ESHRE Andrology Special Interest Group (SIG) Basic Semen Analysis Course methods (this book), the recommendations of the sixth edition of the World Health Organization manual (‘WHO6’) [19], and the reference methods for basic human semen examination published in ISO Standard 23162:2021 [20] which should be adopted by ISO 15189-accredited medical laboratories worldwide.

One matter that has been discussed in relation to semen analysis is the number of specimens that must be analysed from each individual. Quite often at least two specimens are said to be required to get a representative result for the individual [Reference Keel21,Reference Castilla, Alvarez and Aguilar22]. However, when based on laboratory data, a considerable portion of the variability in results can be ascribed to technical variability due to poor quality laboratory methods. Thus, with poor technical quality (including low numbers of spermatozoa assessed) investigations of multiple specimens from the same subject can, at least in part, compensate – but is not cost-efficient either for the patient and their partner or for the laboratory. The reason why epidemiological studies investigating men for possible reproductive toxicological effects only need to produce one specimen is most likely because the variability in individual specimens ‘disappears’ when average values are used and differences in averages between groups can be analysed [Reference Stokes-Riner, Thurston and Brazil23]. Although there is a considerable biological variability in semen analysis results (see Chapter 2), especially concerning sperm concentration, the clinical evaluation of the man does not always require analyses of several ejaculates. For the primary investigation of the man in a subfertile relationship, information from the very first ‘quality’ semen analysis can be enough to direct the continued investigation – either a very poor result indicating the need for direct clinical andrological investigations, or a very good result indicating that further basic semen analyses will not reveal any more pertinent information [Reference Hirsh24Reference Barratt, Björndahl and De Jonge26]. In those subjects with intermediate results, valuable information can be gained from repeated semen analysis. The methods as described in this handbook are designed to minimize variability due to technical factors, and thereby optimize both the evaluation of the man and the laboratory work [Reference Björndahl27].

For the proper use of semen analysis results, appropriate interpretation is fundamental. With a few clear exceptions (e.g. azoospermia), the data cannot provide unambiguous information about the chances of future conception, either in vivo or in vitro. Currently, there is a clear tendency to over-emphasize the value of a single parameter, e.g. strict cut-offs for ‘normal’ sperm morphology as used in ART clinics to decide that ICSI is ‘necessary’. However, as has been known for seven decades, there is a considerable overlap between the semen characteristics of fertile and subfertile men, so no single parameter can be used to provide prognostic information about the fertility potential of the couple [Reference Mortimer, Mortimer, Aitken, Mortimer and Kovacs28,Reference MacLeod and Wang29]. A combination of several variables (motility, morphology and concentration) does give more accurate diagnostic and prognostic information, although there will always be overlaps between what is considered fertile and subfertile [Reference Barratt, Björndahl and De Jonge26,Reference Guzick, Overstreet and Factor-Litvak30,Reference Jedrzejczak, Taszarek-Hauke and Hauke31]. Irrespective of the low predictive value for the reproductive success of the couple, a comprehensive semen analysis provides information about the status of the male reproductive organs, and this is important in the wellbeing of the man. The results of a semen analysis are often used as a sentinel marker for the potential treatment pathway for patients. For example, a primary question in ART clinics remains: is the semen of this man suitable for IUI, or is IVF, or even ICSI, needed? [Reference Mortimer, Mortimer, Aitken, Mortimer and Kovacs28] Primarily, what the clinic is trying to do is determine whether there are indications that the man will have a high likelihood of failure using a particular treatment modality, i.e. the man’s spermatozoa are unsuitable for insemination by IUI, and IVF is indicated. However, despite the plethora of literature surrounding this area, there are still no simple answers. For example, a meta-analysis of the literature trying to ascertain the number of spermatozoa that have been (can be) used as a cut-off for IUI success concluded that there was no such cut-off, and that the data available were of insufficient quality to provide a robust answer [Reference van Weert, Repping and Van Voorhis32]. Of course, the quality of the sperm preparation methodology (and also the products used, see Chapter 9) will also impact on treatment outcome, confounding any simple relationship between pre-treatment semen characteristics and treatment outcome.

For the comprehensive investigation of a man’s fertility potential, it is essential not only to perform a semen analysis, but also that a physical examination be performed and a complete medical history taken [Reference Jequier33]. Accurate interpretation of a semen analysis cannot be made without knowing the patient’s history, and having information from a physical examination and other laboratory investigations, e.g. hormone analyses [Reference Jequier33]. Reduced fertility potential can be secondary to other diseases that should be properly investigated and treated; it is thus irresponsible and unethical to embark upon an infertility work-up without a complete physical examination and history [14,Reference Jequier33].

A common source for misunderstandings and misinterpretations is the use of qualitative terms such as oligozoospermia and asthenozoospermia. Originally, these terms were used to characterize laboratory findings before the quantitative measures had become usable and reliable. But subsequently, these terms have been given precise limits on quantitative scales, creating the false impression of dichotomy (two clearly separated outcomes, like subfertile and fertile), and even a ‘diagnosis’, based on semen characteristics – as opposed to the true situation of a sliding scale between severely infertile (but not sterile) and fertile. In an effort to reduce such confusion in the future, we have abandoned the use of all such qualitative terms and urge everyone working in the field to do likewise. Just describe what you see, as objectively and quantitatively as possible, and interpret the test results within the holistic medical context for the subject, especially the particular circumstances that exist within the reproductive unit of which he is part, i.e. with the female partner, since (sub)fertility is always a feature of a couple.

References

Hull, MG, Glazener, CM, Kelly, NJ, et al. Population study of causes, treatment, and outcome of infertility. Br Med J (Clin Res Ed) 1985; 291: 1693–7.Google Scholar
Andersen, AG, Jensen, TK, Carlsen, E, et al. High frequency of sub-optimal semen quality in an unselected population of young men. Hum Reprod 2000; 15: 366–72.CrossRefGoogle Scholar
Sharpe, RM, Irvine, DS. How strong is the evidence of a link between environmental chemicals and adverse effects on human reproductive health? BMJ 2004; 328: 447–51.Google Scholar
Levine, H, Jørgensen, N, Martino-Andrade, A, et al. Temporal trends in sperm count: a systematic review and meta-regression analysis. Hum Reprod Update 2017; 23: 646–9.Google Scholar
Glazer, CH, Bonde, JP, Eisenberg, ML, et al. Male infertility and risk of nonmalignant chronic diseases: a systematic review of the epidemiological evidence. Semin Reprod Med 2017; 35: 282–90.Google ScholarPubMed
Hanson, MB, Eisenberg, ML, Hotaling, JM. Male infertility: a biomarker of individual and familiar cancer risk. Fertil Steril 2018; 109: 619.Google Scholar
Kasman, AM, Del Giudice, F, Eisenberg, ML. New insights to guide patient care: the bidirectional relationship between male infertility and male health. Fertil Steril 2020; 113: 469–77.CrossRefGoogle ScholarPubMed
Lane, M, Robker, RL, Robertson, SA. Parenting from before conception. Science 2014; 345: 756–60.Google Scholar
Siklenka, K, Erkek, S, Godmann, M, et al. Disruption of histone methylation in developing sperm impairs offspring health transgenerationally. Science 2015; 350: aab2006.Google Scholar
Wright, C. Lifestyle factors and sperm quality. In: Aitken, RJ, Mortimer, D, Kovacs, G, eds. Male and Female Factors That Maximize IVF Success. Cambridge: Cambridge University Press, 2020.Google Scholar
Mortimer, D, Barratt, CL, Björndahl, L, et al. What should it take to describe a substance or product as ‘sperm-safe’. Hum Reprod Update 2013; 19 Suppl 1: i1i45.CrossRefGoogle ScholarPubMed
Barratt, CLR, De Jonge, CJ, Sharpe, RM. ‘Man Up’: the importance and strategy for placing male reproductive health centre stage in the political and research agenda. Hum Reprod 2018; 33: 541–5.Google Scholar
Aitken, RJ. Not every sperm is sacred; a perspective on male infertility. Mol Hum Reprod 2018; 24: 287–98.Google Scholar
Cairo Consensus Workshop Group. The current status and future of andrology: a consensus report from the Cairo workshop group. Andrology 2020; 8: 2752.Google Scholar
Björndahl, L, Barratt, CL. Semen analysis: setting standards for the measurement of sperm numbers. J Androl 2005; 26: 11.Google Scholar
Björndahl, L, Barratt, CL, Mortimer, D, Jouannet, P.How to count sperm properly’: checklist for acceptability of studies based on human semen analysis. Hum Reprod 2016; 31: 227–32.Google ScholarPubMed
Riddell, D, Pacey, A, Whittington, K. Lack of compliance by UK andrology laboratories with World Health Organization recommendations for sperm morphology assessment. Hum Reprod 2005; 20: 3441–5.CrossRefGoogle ScholarPubMed
Zuvela, E, Matson, P. Performance of four chambers to measure sperm concentration: results from an external quality assurance programme. Reprod Biomed Online 2020; 41: 671–8.Google Scholar
World Health Organization. WHO Laboratory Manual for the Examination and Processing of Human Semen, 6th edn. Geneva: World Health Organization, 2021.Google Scholar
International Organization for Standardization. ISO 23162:2021 Basic Semen Examination – Specification and Test Methods. Geneva: International Organization for Standardization, 2021.Google Scholar
Keel, BA. Within- and between-subject variation in semen parameters in infertile men and normal semen donors. Fertil Steril 2006; 85: 128–34.CrossRefGoogle ScholarPubMed
Castilla, JA, Alvarez, C, Aguilar, J, et al. Influence of analytical and biological variation on the clinical interpretation of seminal parameters. Hum Reprod 2006; 21: 847–51.Google Scholar
Stokes-Riner, A, Thurston, SW, Brazil, C, et al. One semen sample or 2? Insights from a study of fertile men. J Androl 2007; 28: 638–43.CrossRefGoogle ScholarPubMed
Hirsh, A. Male subfertility. BMJ 2003; 327: 669–72.Google Scholar
Mishail, A, Marshall, S, Schulsinger, D, Sheynkin, Y. Impact of a second semen analysis on a treatment decision making in the infertile man with varicocele. Fertil Steril 2009; 91: 1809–11.Google Scholar
Barratt, CLR, Björndahl, L, De Jonge, CJ, et al. The diagnosis of male infertility: an analysis of the evidence to support the development of global WHO guidance – challenges and future research opportunities. Hum Reprod Update 2017; 23: 660–80.Google Scholar
Björndahl, L. What is normal semen quality? On the use and abuse of reference limits for the interpretation of semen analysis results. Hum Fertil 2011; 14: 179–86.Google Scholar
Mortimer, D, Mortimer, ST. The case against intracytoplasmic sperm injection for all. In: Aitken, RJ, Mortimer, D, Kovacs, G, eds. Male and Female Factors That Maximize IVF Success. Cambridge: Cambridge University Press, 2020.Google Scholar
MacLeod, J, Wang, Y. Male fertility potential in terms of semen quality: a review of the past, a study of the present. Fertil Steril 1979; 31: 103–16.Google Scholar
Guzick, DS, Overstreet, JW, Factor-Litvak, P, et al. National Cooperative Reproductive Medicine Network. Sperm morphology, motility, and concentration in fertile and infertile men. N Engl J Med 2001; 345: 1388–93.CrossRefGoogle ScholarPubMed
Jedrzejczak, P, Taszarek-Hauke, G, Hauke, J, et al. Prediction of spontaneous conception based on semen parameters. Int J Androl 2008; 31: 499507.CrossRefGoogle ScholarPubMed
van Weert, JM, Repping, S, Van Voorhis, BJ, et al. Performance of the postwash total motile sperm count as a predictor of pregnancy at the time of intrauterine insemination: a meta-analysis. Fertil Steril 2004; 82: 612–20.CrossRefGoogle ScholarPubMed
Jequier, AM. The importance of diagnosis in the clinical management of infertility in the male. Reprod Biomed Online 2006; 13: 331–5.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×